Study of Olaparib in Metastatic Renal Cell Carcinoma Patients With DNA Repair Gene Mutations

NCT03786796 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

20

Enrollment

OTHER

Sponsor class

Conditions

Renal Cell Carcinoma
Metastatic Renal Cell Carcinoma
Kidney Cancer
Renal Carcinoma
Kidney Cancer Metastatic

Interventions

DRUG: Olaparib

Sponsor

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

Collaborators

[object Object]